ArriVent BioPharma Reports Second Quarter 2026 Financial Results

Go back to ArriVent BioPharma Reports Second Quarter 2026 Financial Results
(NASDAQ: AVBP) Delayed: 29.18 -0.84 (2.8%)
Previous Close $30.02    52 Week High
Open $29.73    52 Week Low
Day High $29.81    P/E N/A 
Day Low $28.64    EPS
Volume 406,273